Peter M. Neupert

Peter M. Neupert is a declared insider at 3 companies (board member); the most frequent names are Adaptive Biotechnologies Corp, Labcorp Holdings Inc. and Fortrea Holdings Inc. Over a trading history stretching from 26 January 2022 to 17 August 2026, the count stands at 22 filings.

Market trades split into 3 purchases (€731k) and 3 sales (€2.7M). The net balance comes to €2.0M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 5 share grants and 11 option exercises. 2026 to date brings no purchases and 3 sales.

In size, the median ticket on the buying side is €256k. On 1 out of 3 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 19 August 2026: an option exercise of €82k, in Adaptive Biotechnologies Corp. The latest purchase dates back some time: it was published 433 days ago, on 11 August 2025. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.